Loading chat...
NY S00559
Bill
Status
12/30/2022
Primary Sponsor
Peter Harckham
Click for details
AI Summary
-
Department of Health must request guidance from Centers for Medicare and Medicaid Services within 30 days of the act's effective date regarding federal financial participation for prescription digital therapeutics (PDTs)
-
Guidance request focuses on whether New York can claim federal funding for coverage and payment of FDA-approved PDTs used to treat substance use and opioid use disorders
-
Prescription digital therapeutics are software-based disease treatments tested for safety and efficacy in clinical trials, prescribed by healthcare providers, and designed to provide remote treatment modalities
-
Legislation addresses access gaps created by coronavirus pandemic mitigation efforts that reduced in-person treatment availability for individuals in recovery from substance use disorders and mental health conditions
-
Act takes effect immediately upon enactment
Legislative Description
Directs the department of health to request guidance from the Centers for Medicare and Medicaid Services to determine whether the state can claim federal financial participation for coverage of and payment for certain prescription digital therapeutics.
Last Action
APPROVAL MEMO.102
12/30/2022